IT1284524B1 - Uso di proteine come agenti anti-retrovirali - Google Patents

Uso di proteine come agenti anti-retrovirali

Info

Publication number
IT1284524B1
IT1284524B1 IT96MI001884A ITMI961884A IT1284524B1 IT 1284524 B1 IT1284524 B1 IT 1284524B1 IT 96MI001884 A IT96MI001884 A IT 96MI001884A IT MI961884 A ITMI961884 A IT MI961884A IT 1284524 B1 IT1284524 B1 IT 1284524B1
Authority
IT
Italy
Prior art keywords
proteins
retroviral agents
retroviral
agents
Prior art date
Application number
IT96MI001884A
Other languages
English (en)
Inventor
Giuli Morghen Carlo De
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT96MI001884A priority Critical patent/IT1284524B1/it
Application filed by Zetesis Spa filed Critical Zetesis Spa
Priority to PCT/EP1997/004966 priority patent/WO1998011137A1/en
Priority to EP97943858A priority patent/EP0925309A1/en
Priority to AU45547/97A priority patent/AU719203B2/en
Priority to IL12896897A priority patent/IL128968A0/xx
Priority to JP10513259A priority patent/JP2001500857A/ja
Priority to NZ334634A priority patent/NZ334634A/xx
Priority to RU99107378/14A priority patent/RU2203071C2/ru
Priority to KR1019997002114A priority patent/KR20000036096A/ko
Priority to CA002265445A priority patent/CA2265445A1/en
Priority to PL97332158A priority patent/PL188745B1/pl
Priority to CZ99890A priority patent/CZ89099A3/cs
Priority to HU9904262A priority patent/HUP9904262A3/hu
Priority to ARP970104177A priority patent/AR009760A1/es
Priority to US09/254,722 priority patent/US6207200B1/en
Priority to BR9711789A priority patent/BR9711789A/pt
Priority to CN97198246A priority patent/CN1231674A/zh
Priority to TR1999/00555T priority patent/TR199900555T2/xx
Priority to ZA9708233A priority patent/ZA978233B/xx
Publication of ITMI961884A1 publication Critical patent/ITMI961884A1/it
Application granted granted Critical
Publication of IT1284524B1 publication Critical patent/IT1284524B1/it
Priority to NO991174A priority patent/NO991174L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT96MI001884A 1996-09-13 1996-09-13 Uso di proteine come agenti anti-retrovirali IT1284524B1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT96MI001884A IT1284524B1 (it) 1996-09-13 1996-09-13 Uso di proteine come agenti anti-retrovirali
CZ99890A CZ89099A3 (cs) 1996-09-13 1997-09-11 Použití bílkovin, extrahovatelných z jater savců
AU45547/97A AU719203B2 (en) 1996-09-13 1997-09-11 Use of proteins as anti-retroviral agents
IL12896897A IL128968A0 (en) 1996-09-13 1997-09-11 Use of proteins as anti-retroviral agents
JP10513259A JP2001500857A (ja) 1996-09-13 1997-09-11 抗レトロウイルス剤としてのタンパク質の使用
NZ334634A NZ334634A (en) 1996-09-13 1997-09-11 Use of a protein extracted from mammalian liver for treating HIV
RU99107378/14A RU2203071C2 (ru) 1996-09-13 1997-09-11 Применение белков в качестве антиретровирусных агентов
KR1019997002114A KR20000036096A (ko) 1996-09-13 1997-09-11 항레트로바이러스제로서의 단백질의 용도
CA002265445A CA2265445A1 (en) 1996-09-13 1997-09-11 Use of proteins as anti-retroviral agents
ARP970104177A AR009760A1 (es) 1996-09-13 1997-09-11 El uso de proteinas como agentes anti-retrovirales
PCT/EP1997/004966 WO1998011137A1 (en) 1996-09-13 1997-09-11 Use of proteins as anti-retroviral agents
EP97943858A EP0925309A1 (en) 1996-09-13 1997-09-11 Use of proteins as anti-retroviral agents
PL97332158A PL188745B1 (pl) 1996-09-13 1997-09-11 Zastosowanie aktywnego białka do leczenia zakażeńwirusem HIV
US09/254,722 US6207200B1 (en) 1996-09-13 1997-09-11 Use of proteins as anti-retroviral agents
BR9711789A BR9711789A (pt) 1996-09-13 1997-09-11 Uso de prote nas como agentes anti-retrovirais
CN97198246A CN1231674A (zh) 1996-09-13 1997-09-11 作为抗逆转录病毒试剂的蛋白的用途
TR1999/00555T TR199900555T2 (xx) 1996-09-13 1997-09-11 Vir�slerin v�cuda yeniden yerle�mesini �nleyici madde olarak proteinerin kullan�m�.
HU9904262A HUP9904262A3 (en) 1996-09-13 1997-09-11 Use of proteins as anti-retroviral agents
ZA9708233A ZA978233B (en) 1996-09-13 1997-09-12 The use of protein as anti-retroviral agents.
NO991174A NO991174L (no) 1996-09-13 1999-03-10 Anvendelse av proteiner som anti-retrovirale midler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001884A IT1284524B1 (it) 1996-09-13 1996-09-13 Uso di proteine come agenti anti-retrovirali

Publications (2)

Publication Number Publication Date
ITMI961884A1 ITMI961884A1 (it) 1998-03-13
IT1284524B1 true IT1284524B1 (it) 1998-05-21

Family

ID=11374877

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI001884A IT1284524B1 (it) 1996-09-13 1996-09-13 Uso di proteine come agenti anti-retrovirali

Country Status (20)

Country Link
US (1) US6207200B1 (it)
EP (1) EP0925309A1 (it)
JP (1) JP2001500857A (it)
KR (1) KR20000036096A (it)
CN (1) CN1231674A (it)
AR (1) AR009760A1 (it)
AU (1) AU719203B2 (it)
BR (1) BR9711789A (it)
CA (1) CA2265445A1 (it)
CZ (1) CZ89099A3 (it)
HU (1) HUP9904262A3 (it)
IL (1) IL128968A0 (it)
IT (1) IT1284524B1 (it)
NO (1) NO991174L (it)
NZ (1) NZ334634A (it)
PL (1) PL188745B1 (it)
RU (1) RU2203071C2 (it)
TR (1) TR199900555T2 (it)
WO (1) WO1998011137A1 (it)
ZA (1) ZA978233B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6724339B2 (en) * 2001-03-14 2004-04-20 Universal Electronics Inc. System and method for controlling home appliances
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
RU2062096C1 (ru) * 1993-08-19 1996-06-20 Лебедев Василий Вячеславович Средство для лечения иммунодефицитных состояний
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra

Also Published As

Publication number Publication date
PL188745B1 (pl) 2005-04-29
AU4554797A (en) 1998-04-02
PL332158A1 (en) 1999-08-30
AR009760A1 (es) 2000-05-03
NO991174L (no) 1999-05-05
CZ89099A3 (cs) 1999-08-11
ZA978233B (en) 1998-04-01
NZ334634A (en) 2000-08-25
EP0925309A1 (en) 1999-06-30
TR199900555T2 (xx) 1999-05-21
IL128968A0 (en) 2000-02-17
HUP9904262A2 (hu) 2000-04-28
CN1231674A (zh) 1999-10-13
JP2001500857A (ja) 2001-01-23
NO991174D0 (no) 1999-03-10
KR20000036096A (ko) 2000-06-26
US6207200B1 (en) 2001-03-27
BR9711789A (pt) 1999-08-24
RU2203071C2 (ru) 2003-04-27
WO1998011137A1 (en) 1998-03-19
AU719203B2 (en) 2000-05-04
ITMI961884A1 (it) 1998-03-13
HUP9904262A3 (en) 2001-11-28
CA2265445A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
ITMI941466A0 (it) Uso di derivati di chinolina
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
BR9707501A (pt) Composto composição farmacêutica e uso do composto
BR9707808A (pt) Composto composição farmacêutica e uso do composto
NO984662L (no) Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger
BR0009767A (pt) Agentes inibitórios e quimiotáticos derivados de osteopontina e seus usos
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
DK0928197T3 (da) Anvendelse af proteiner som midler mod autoimmune sygdomme
BR7401412U (pt) Estojo de uso pessoal
ID16838A (id) Komposisi dekafluoropentana
MA26544A1 (fr) Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles
TR199701666A3 (tr) Sismanliga karsi proteinler
ID17419A (id) Komposisi dekafluoropentana
NO993354L (no) Voksholdige preparater
NO991174L (no) Anvendelse av proteiner som anti-retrovirale midler
DE69821717D1 (de) Arbeitseinheit
ID22787A (id) Nitro-benzamida berguna sebagai zat anti - arritimia
ITMI930554A1 (it) Uso di proteine per il trattamento di stati infiammatori
ITFI920146A0 (it) Proteine funzionalizzate e loro uso per la preparazione di coniugati
KR980000501U (ko) 작업용 이동 의자
IT1307329B1 (it) Uso di derivati di idroisochinolina
FI971253L (fi) Lyoluminesenssin käyttö analyyttisiin tarkoituksiin
NO943136L (no) Vippbar arbeids- eller kontorstol
ITGE920115A1 (it) Uso di 4 -isopropilbenzilsalicilato come antilipoperossidante cutaneo.
FR2763940B1 (fr) Preparation de trifluoromethoxy-2-aniline

Legal Events

Date Code Title Description
0001 Granted